This study delves into the role of PELI1 in activating the PI3K/AKT/GSK3β pathway through the ubiquitination modification of RPS3, concurrently participating in the degradation of p53 to propel the malignant behaviour of PC. Here, TP53 is linked to pachyonychia congenita.